Yoshimi Aoyagi

Antitumor Activity of a Novel Quinoline Derivative, TAS‐103, with Inhibitory Effects on Topoisomerases I and II

Teruhiro Utsugi, Kumio Aoyagi, Tetsuji Asao et al. · Japanese Journal of Cancer Research · 1997 · 116 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations

Shinichi Hasako, Miki Terasaka, Naomi Abe et al. · Molecular Cancer Therapeutics · 2018 · 85 citations

Medicine, Oncology, Pharmacology +17

Synthesis of the novel analogues of dysidiolide and their structure–activity relationship

Masato Takahashi, Kosuke Dodo, Yoshikazu Sugimoto et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 62 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +12

<i>In vitro</i> Antitumor Activity of TAS‐103, a Novel Quinoline Derivative That Targets Topoisomerases I and II

Yoshimi Aoyagi, Takashi Kobunai, Teruhiro Utsugi et al. · Japanese Journal of Cancer Research · 1999 · 41 citations · Full text

Medicine, Oncology, Pharmacology +13

New Cdc25B Tyrrosine Phosphatase Inhibitors, Nocardiones A and B, Produced by Nocardia sp. TP-A0248. Taxonomy, Fermentation, Isolation, Structural Elucidation and Biological Prbperties.

TOSHIO OTANI, Yoshikazu Sugimoto, Yoshimi Aoyagi et al. · The Journal of Antibiotics · 2000 · 40 citations · Full text

Life Sciences, Microbiology, Molecular Biology +7